Richard J. Rodgers - 29 Oct 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/Mark J. Casey, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
29 Oct 2024
Net transactions value
$0
Form type
4
Filing time
02 Jan 2025, 16:52:22 UTC
Previous filing
17 Jun 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $0 +3,800 +36% $0.000000 14,270 29 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -3,800 -50% $0.000000 3,800 29 Oct 2024 Common Stock 3,800 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.